维普中文期刊产品整合服务
19篇 您的检索式:作者名="VADIAKA M"
    题名 作者 年代 出处 被引量
1显示文摘Kosmas C Tsavaris N Vadiaka M 2001Cancer2001,92,11:1
2Immune changes in pa- tients with advanced breast cancer undergoing chemotherapy with taxane显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,1:1
3Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy - a survey of 427 patients显示文摘Tsavaris N Kosmas C Vadiaka M 2002Med Sci Monit2002,8,6:1
4Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,1:1
5Immune changes in patientswith advanced breast cancer undergoing chemotherapy with taxanes显示文摘Tsavaris N Kosmas C Vadiaka M 0,,01:1
65-Fluorouracil cardiotoxieity is a rare, dose and schedule- dependent adverse event: a prospective study显示文摘TSAVARIS N KOSMAS C VADIAKA M 2005J BUON2005,10,2:1
7Gemcitabine and docetaxel as second-line chemotherapy in non-small cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens显示文摘 Tsavaris N Vadiaka M 2001Cancer2001,92,11:1
8Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,1:1
9Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV )non-Hodgkin's lymphoma 显示文摘Tsavaris N Kosmas C Vadiaka M 2002Anticancer Res2002,22,:1
10Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced coloreetal cancer: a pilot study 显示文摘Tsavaris N Kosmas C Vadiaka M 2002Invest New Drugs2002,20,1:1
11Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes 显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,1:1
12Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens显示文摘Demir C Tsavaris N Vadiaka M 2004Cancer2004,92,11:1
13A simplified premedieation schedule for 1-hour paelitaxel administration 显示文摘TSAVARIS N KOSMAS C VADIAKA M 2005Support Oncol2005,3,1:1
14Immue changes in patients with advanced breast cancer undergoing chemotheraph with taxanes 显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,1:1
15Raltitrexed(tomudex)administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer:a pilot study 显示文摘TSAVARIS N KOSMAS C VADIAKA M 2002Invest New Drugs2002,20,1:1
16Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients显示文摘Tsavaris N Kosmas C Vadiaka M 2002Med Sci Monit2002,8,6:1
17Pegylated liposomal doxo- rubicin in the CHOP regimen for older patients with aggres- sive(stages IU/IV)non-Hodgkin's lymphoma显示文摘Tsavaris N Kosmas C Vadiaka M 2002Anticancer Res2002,22,3:1
18Immurle changes in patients with advanced breast cancer undergoing chemotherapy with taxanes 显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,:1
19Immune changes in pa- tients with advanced breast cancer undergoing chemotherapy with taxanes 显示文摘Tsavaris N Kosmas C Vadiaka M 2002Br J Cancer2002,87,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费